Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 DOD OTA AGREEMENT LEVERAGED BY INTERAGENCY FOR COVID-19 RAPID RESPONSE
2 Joint Services CBRND Office Realigns To Focus On Protection, Sensors And Medical
3 JPEO-CBRND Works with Industry to Develop COVID-19 Diagnostic Tests
4 Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19
5 DOD LEVERAGING DIAGNOSTIC PLATFORM FOR COVID-19 RAPID RESPONSE
6 CCDC Chemical Biological Center Helps Air Force Design, Test and Field Large-Scale COVID-19 Transport Capability in Record Time
7 Just
8 SIGA Technologies Announces Department of Defense Increases Funding to Develop Post-Exposure Prophylactic Indication for TPOXX®
9 Equine Encephalitis Virus Vaccine Shows Positive Study Results
10 Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent's COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with US Department of Defense Funding
11 Mount Sinai, Emergent, And ImmunoTek Form Collaboration
12 JPEO-CBD Activates New Joint Project Management Office of Medical Countermeasure Systems (MCS)
13 Exton's Immunome Awarded Department of Defense Contract to Develop Biosynthetic Convalescent Plasma for COVID-19
14 MVA-BN WEV Equine Encephalitis Vaccine — Precision Vaccinations
15 Fort Detrick part of FDA-approved Ebola vaccine
16 Fort Detrick Installation Utilizes Whole of Government Approach to Tackle COVID-19
17 Latest sensor upgrades boost recon vehicle capabilities
18 Bavarian Nordic Announces Initiation of Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
19 Why Inovio Pharmaceuticals (INO) Stock Jumped Over 700% This Year
20 ERVEBO Ebola Vaccine — Precision Vaccinations
21 AirBoss Announces US$96 Million Contract for FlexAir™ PAPR System from FEMA to Help Battle COVID-19
22 DCS awarded $50.2M Joint Warning and Reporting Network (JWARN) Contract
23 Tauri Group Awarded Two Task Orders under OPETS
24 INOVIO Receives Orphan Drug Designation From U.S. FDA for DNA Medicine INO-3107 To Treat Rare Disease Recurrent Respiratory Papillomatosis (RRP)
25 INOVIO Receives $71 Million Contract From U.S. Department of Defense To Scale Up Manufacture of CELLECTRA® 3PSP Smart Device and Procurement of CELLECTRA® 2000 for COVID-19 DNA Vaccine
26 Sitemap
27 Inovio Pharmaceuticals
28 Inovio Pharma (INO) Adds Thermo Fisher Scientific (TMO) To Global Manufacturing Consortium
29 INOVIO to Report Second Quarter 2020 Financial Results on August 10, 2020
30 Inovio Pharmaceuticals
31 Inovio Pharmaceuticals
32 Inovio Pharmaceuticals
33 Inovio Pharmaceuticals
34 INOVIO to Present at Upcoming Investor Conferences in September
35 Inovio Pharmaceuticals
36 Inovio Pharmaceuticals
37 Department of Defense Awards Ology Bioservices Contract to Advance Anti-Botulinum Neurotoxin Monoclonal Antibodies
38 INOVIO Expands Senior Management Team
39 INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus
40 Autoinjectors Offer Way to Treat Prolonged Seizures
41 CytoDyn's COVID-19 Trial Tribulations
42 'Insanely Stupid' To Chase Stocks As Economy Plunges?
43 Latest sensor upgrades boost US reconnaissance vehicle capabilities
44 SAB Biotherapeutics Advances Therapeutic for COVID-19 in Partnership with Department of Defense and BARDA
45 INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models
46 INOVIO to Host its Annual Meeting of Stockholders in Virtual Format and at a New Time